SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) announces the three recipients who have been awarded its 2014 Affymetrix Tumor Profiling Grant. The goal of this grant program is to support translational cancer research in discovery and analytical validation of biomarkers that may address current unmet clinical needs in cancer diagnosis, prognosis, and treatment. Research projects considered for the grant use the approach of parallel analysis of multiple molecular and cellular parameters which enables faster identification of the most robust biomarkers for applications in the clinic with impactful outcome.
Help employers find you! Check out all the jobs and post your resume.
